We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Marriott International
MAR
$98.3B
| $7.01M | 0.35% |
50,000
| – | – |
|
|
ARRY
77
CALL
DELISTED
Array Biopharma Inc
ARRY
| $6.95M | 0.35% |
150,000
+84,000
| +127% | +$2.36M |
|
|
ARRY
78
PUT
DELISTED
Array Biopharma Inc
ARRY
| $6.95M | 0.35% |
+150,000
| New | +$4.21M |
|
|
79
PUT
Crocs
CROX
$6.14B
| $6.95M | 0.35% |
351,800
+200
| +0.1% | +$4.63K |
|
80
PUT
Madrigal Pharmaceuticals
MDGL
$10.8B
| $6.92M | 0.35% |
66,000
+11,100
| +20% | +$1.19M |
|
|
SAGE
81
PUT
DELISTED
Sage Therapeutics
SAGE
| $6.87M | 0.35% |
37,500
+5,500
| +17% | +$938K |
|
|
82
CALL
Madrigal Pharmaceuticals
MDGL
$10.8B
| $6.8M | 0.34% |
64,900
-35,900
| -36% | -$3.85M |
|
83
CALL
Targa Resources
TRGP
$58B
| $6.48M | 0.33% |
165,000
+90,000
| +120% | +$3.57M |
|
84
PUT
Galicia Financial Group
GGAL
$7.99B
| $6.45M | 0.32% |
+181,800
| New | +$4.87M |
|
85
PUT
Itron
ITRI
$4.36B
| $6.43M | 0.32% |
+102,800
| New | +$5.71M |
|
|
86
Crocs
CROX
$6.14B
| $6.42M | 0.32% |
325,000
+219,000
| +207% | +$5.07M |
|
87
PUT
SolarEdge
SEDG
$2.51B
| $6.25M | 0.31% |
+100,000
| New | +$5.05M |
|
|
ONCE
88
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.25M | 0.31% |
61,000
+34,000
| +126% | +$3.67M |
|
|
89
Tapestry
TPR
$30.8B
| $6.19M | 0.31% |
195,000
-385,000
| -66% | -$12M |
|
90
Twilio
TWLO
$30B
| $6M | 0.3% |
44,000
+4,000
| +10% | +$533K |
|
|
CZR
91
DELISTED
Caesars Entertainment Corporation
CZR
| $5.94M | 0.3% |
502,300
+322,300
| +179% | +$3.05M |
|
|
EXAS
92
CALL
DELISTED
Exact Sciences
EXAS
| $5.9M | 0.3% |
50,000
-43,000
| -46% | -$4.33M |
|
93
CALL
Apollo Global Management
APO
$72.4B
| $5.88M | 0.3% |
171,600
+800
| +0.5% | +$25.4K |
|
94
CALL
Unum
UNM
$13.6B
| $5.87M | 0.3% |
+175,000
| New | +$6.06M |
|
|
95
PUT
Unum
UNM
$13.6B
| $5.87M | 0.3% |
+175,000
| New | +$6.06M |
|
96
PUT
Coty
COTY
$2.42B
| $5.83M | 0.29% |
+434,800
| New | +$5.34M |
|
|
DFS
97
CALL
DELISTED
Discover Financial Services
DFS
| $5.82M | 0.29% |
+75,000
| New | +$5.81M |
|
|
SGMO
98
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.81M | 0.29% |
539,700
+504,700
| +1,442% | +$5.37M |
|
99
Franklin Covey
FC
$242M
| $5.78M | 0.29% |
170,000
+32,069
| +23% | +$951K |
|
|
100
Marathon Petroleum
MPC
$92.4B
| $5.59M | 0.28% |
+100,000
| New | +$5.47M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.